The Promise That Didn’t Deliver Novo Nordisk, the Danish pharmaceutical giant behind blockbuster drugs like Ozempic and Wegovy, has confirmed that its late‑stage trial of an older oral version of semaglutide failed to meet its main goal. The trial aimed to test whether the drug could slow cognitive decline in patients with Alzheimer’s disease. The…
The 2025 regulatory agenda is more than a list of coming rules. It’s a roadmap. For businesses, it’s a signal. Regulators are laying out their priorities — and it won’t be business as usual. From climate to cybersecurity, health to labor, the changes coming could reshape your operations, your costs, and your strategy. First, the…
The Announcement The Department of Health and Human Services confirmed that Ralph Abraham, Louisiana’s surgeon general, has been tapped to serve as the CDC’s principal deputy director. This position is second only to the director, a role currently vacant, meaning Abraham will essentially be running the agency. The appointment has already sparked debate. Abraham is…
Setting the Scene When President Donald Trump welcomed New York City Mayor‑elect Zohran Mamdani into the Oval Office, expectations were low. Trump had spent months calling Mamdani a “communist,” while Mamdani had branded Trump a “fascist” and “despot.” Yet what unfolded was not a clash of insults but a surprisingly cordial exchange. The meeting lasted…
The Unprecedented Move The Pentagon confirmed it is investigating Democratic Senator Mark Kelly, a retired U.S. Navy captain and former astronaut. Officials said they had received serious allegations of misconduct and were considering recalling him to active duty. Such a recall would allow the military to pursue a court‑martial or administrative punishment. This is not…
In 2025, SEC disclosure rules are tightening in ways financial firms can no longer ignore. Transparency is no longer just a regulatory checkbox — it’s becoming a core business expectation. Investors want clarity. Regulators want accuracy. And firms are being pushed to upgrade how they report everything from cybersecurity risks to climate exposures. The message…
The Courtroom Decision In a dramatic turn, a federal judge threw out the criminal cases against James Comey and Letitia James. The ruling centered not on the substance of the charges but on the legality of the prosecutor’s appointment. Judge Cameron McGowan Currie declared that the attempt to install Lindsey Halligan as interim U.S. Attorney…
On November 17, 2025, U.S. stock indexes fell as investors grew cautious ahead of key earnings and economic data. Tech stocks led the decline, with Nvidia in focus ahead of its earnings release. Major Indexes Decline Across the Board The Dow Jones Industrial Average dropped 557.24 points, or 1.18%, closing at 46,590.24. The S&P 500…
On November 19, 2025, during a public court hearing in Alexandria, Virginia, federal prosecutors acknowledged that the full grand jury did not review the final version of the indictment against former FBI Director James Comey. The admission has raised legal and procedural concerns, prompting Comey’s legal team to seek dismissal of the charges. Final Indictment…
Congress Demands Transparency In a rare show of bipartisan unity, the U.S. House of Representatives voted 427–1 to pass the Epstein Files Transparency Act, which mandates the Department of Justice (DOJ) to release all unclassified records related to Jeffrey Epstein and his convicted accomplice, Ghislaine Maxwell. The Senate approved the bill shortly after, sending it…